262 related articles for article (PubMed ID: 17239135)
21. Analysis of alpha-fetoprotein mRNA level on the tumor cell hematogenous spread of patients with hepatocellular carcinoma undergoing orthotopic liver transplantation.
Wang YL; Li G; Wu D; Liu YW; Yao Z
Transplant Proc; 2007; 39(1):166-8. PubMed ID: 17275497
[TBL] [Abstract][Full Text] [Related]
22. [Recurrence and metastasis of hepatocellular carcinoma after liver transplantation: single center experiences].
Zheng SS; Chen J; Wang WL; Zhang M; Shen Y; Wu J; Xu X; Yan S
Zhonghua Wai Ke Za Zhi; 2008 Nov; 46(21):1609-13. PubMed ID: 19094751
[TBL] [Abstract][Full Text] [Related]
23. Surgical treatment of hepatocellular carcinoma beyond Milan criteria. Results of liver resection, salvage transplantation, and primary liver transplantation.
Facciuto ME; Koneru B; Rocca JP; Wolf DC; Kim-Schluger L; Visintainer P; Klein KM; Chun H; Marvin M; Rozenblit G; Rodriguez-Davalos M; Sheiner PA
Ann Surg Oncol; 2008 May; 15(5):1383-91. PubMed ID: 18320284
[TBL] [Abstract][Full Text] [Related]
24. Liver transplantation for solitary hepatocellular carcinoma less than 3 cm in diameter in Child A cirrhosis.
Poon RT
Dig Dis; 2007; 25(4):334-40. PubMed ID: 17960069
[TBL] [Abstract][Full Text] [Related]
25. Des-gamma-carboxyprothrombin, alpha-fetoprotein and AFP-L3 in patients with chronic hepatitis, cirrhosis and hepatocellular carcinoma.
Durazo FA; Blatt LM; Corey WG; Lin JH; Han S; Saab S; Busuttil RW; Tong MJ
J Gastroenterol Hepatol; 2008 Oct; 23(10):1541-8. PubMed ID: 18422961
[TBL] [Abstract][Full Text] [Related]
26. Liver transplantation for hepatocellular carcinoma without preoperative tumor biopsy.
Compagnon P; Grandadam S; Lorho R; Turlin B; Camus C; Jianrong Y; Lainé F; Meunier B; Deugnier Y; Boudjema K
Transplantation; 2008 Oct; 86(8):1068-76. PubMed ID: 18946344
[TBL] [Abstract][Full Text] [Related]
27. Liver transplantation for hepatocellular carcinoma with intrahepatic lymphatic invasion: case reports.
Sotiropoulos GC; Molmenti EP; Fouzas I; Sgourakis G; Radtke A; Malagó M; Lang H
Transplant Proc; 2008 Nov; 40(9):3213-4. PubMed ID: 19010238
[TBL] [Abstract][Full Text] [Related]
28. Laparoscopic staging and radiofrequency of hepatocellular carcinoma in liver ci rrhosis. A "bridge" treatment to liver transplantation.
Casaccia M; Andorno E; Nardi I; Santori G; Troilo B; Barabino G; Di Domenico S; Panaro F; Valente U
Hepatogastroenterology; 2009; 56(91-92):793-7. PubMed ID: 19621704
[TBL] [Abstract][Full Text] [Related]
29. A revised scoring system utilizing serum alphafetoprotein levels to expand candidates for living donor transplantation in hepatocellular carcinoma.
Yang SH; Suh KS; Lee HW; Cho EH; Cho JY; Cho YB; Kim IH; Yi NJ; Lee KU
Surgery; 2007 May; 141(5):598-609. PubMed ID: 17462459
[TBL] [Abstract][Full Text] [Related]
30. Patient with hepatocellular carcinoma on the waiting list for liver transplantation: abdominal seeding due to prior surgery: a case report.
Aydin U; Yazici P; Sozbilen M; Kece C; Tamsel S; Kilic M
Transplant Proc; 2007 Jun; 39(5):1688-90. PubMed ID: 17580221
[TBL] [Abstract][Full Text] [Related]
31. HCC in living donor liver transplantation: can we expand the Milan criteria?
Kwon CH; Kim DJ; Han YS; Park JB; Choi GS; Kim SJ; Joh JW; Lee SK
Dig Dis; 2007; 25(4):313-9. PubMed ID: 17960066
[TBL] [Abstract][Full Text] [Related]
32. [Liver transplantation for hepatocellular carcinoma].
Tanaka A; Tanaka K; Kaihara S; Ueda M; Uemoto S; Kiuchi T; Egawa H
Nihon Rinsho; 2001 Oct; 59 Suppl 6():705-16. PubMed ID: 11762042
[No Abstract] [Full Text] [Related]
33. [Biliary atresia and polysplenia syndrome: outcome and growth post-transplantation].
López EJ; Iglesias Berengue J; Ortega López J; Asensio Llorente M; Creixell CM; Yeste Fernández D; Carrascosa Lezcano A
Cir Pediatr; 2004 Jan; 17(1):21-4. PubMed ID: 15005077
[TBL] [Abstract][Full Text] [Related]
34. Is liver transplantation justified for the treatment of HCC in Child's A patients? Not always.
Esquivel CO
Liver Transpl; 2003 May; 9(5):521-2. PubMed ID: 12740797
[No Abstract] [Full Text] [Related]
35. Liver transplantation for hepatocellular carcinoma.
Heimbach JK
Cancer J; 2008; 14(2):95-9. PubMed ID: 18391614
[TBL] [Abstract][Full Text] [Related]
36. How should patients with hepatocellular carcinoma recurrence after liver transplantation be treated?
Schwartz M; Roayaie S; Llovet J
J Hepatol; 2005 Oct; 43(4):584-9. PubMed ID: 16120468
[No Abstract] [Full Text] [Related]
37. De novo sirolimus-based immunosuppression after liver transplantation for hepatocellular carcinoma: long-term outcomes and side effects.
Toso C; Meeberg GA; Bigam DL; Oberholzer J; Shapiro AM; Gutfreund K; Ma MM; Mason AL; Wong WW; Bain VG; Kneteman NM
Transplantation; 2007 May; 83(9):1162-8. PubMed ID: 17496530
[TBL] [Abstract][Full Text] [Related]
38. Liver transplantation for hepatocellular carcinoma in patients who do not meet the Milan criteria.
Suh KS; Cho EH; Lee HW; Shin WY; Yi NJ; Lee KU
Dig Dis; 2007; 25(4):329-33. PubMed ID: 17960068
[TBL] [Abstract][Full Text] [Related]
39. Biliary atresia.
Chardot C
Orphanet J Rare Dis; 2006 Jul; 1():28. PubMed ID: 16872500
[TBL] [Abstract][Full Text] [Related]
40. Recurrent hepatocellular carcinoma after transplantation: use of a pathological score on explanted livers to predict recurrence.
Parfitt JR; Marotta P; Alghamdi M; Wall W; Khakhar A; Suskin NG; Quan D; McAllister V; Ghent C; Levstik M; McLean C; Chakrabarti S; Garcia B; Driman DK
Liver Transpl; 2007 Apr; 13(4):543-51. PubMed ID: 17394152
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
